1887

Abstract

Human immunodeficiency virus type 1 and V3 sequences from 15 homosexual men and 19 intravenous drug users in the Amsterdam Cohort studies were analysed. Previously, we reported that V3 domains of viruses from drug users are distinguishable from those of homosexual men on the basis of two silent mutations. Phylogenetic analysis of and V3 shows that differences in all three regions correlate with risk group. Two positions in both and were found to differ significantly between the risk groups. The distinguishing positions were confirmed for sequences from 11 Scottish and four German samples. The three regions show relatively independent evolution patterns; they resulted in different phylogenies, the only stable clustering being that based on the risk group distinction. Pairwise differences between sequences of the genes were moderately correlated (around 0.30). Surprisingly, when only silent changes were counted, the correlations dropped almost to zero, indicating that the evolution towards independence was more advanced in the silent than in the non-silent positions. This suggests that selection at the amino acid level is not the primary driving force for the independent evolutionary behaviour of the genes. Recombination, combined with restrictions on certain amino acids because of epistatic interactions between the genes, could be an alternative explanation of this phenomenon.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-77-4-783
1996-04-01
2021-10-19
Loading full text...

Full text loading...

/deliver/fulltext/jgv/77/4/JV0770040783.html?itemId=/content/journal/jgv/10.1099/0022-1317-77-4-783&mimeType=html&fmt=ahah

References

  1. Albert J., Wahlberg J., Leitner T., Escanilla D., Uhlen M. 1994; Analysis of a rape case by direct sequencing of the human immunodeficiency virus type 1 pol and gag genes. Journal of Virology 68:5918–5924
    [Google Scholar]
  2. Balliet J. W., Kolson D. L., Eiger G., Kim F. M., McGann K. A., Srinivasan A., Collman R. 1994; Distinct effect in primary macrophages and lymphocytes of the human immunodeficiency virus type 1 accessory genes vpr, vpu and nef: mutational analysis of a primary HIV-1 isolate. Virology 200:623–631
    [Google Scholar]
  3. Balotta C., Lusso P., Crowley R., Gallo R. C., Franchini G. 1994; Antisense phosphorothioate oligodeoxynucleotides targeted to the vpr gene inhibit human immunodeficiency virus type 1 replication in primary human macrophages. Journal of Virology 67:4409–4414
    [Google Scholar]
  4. Boom R., Sol C. J. A., Salimans M. M. M., Jansen C. L., Wertheim-Van Dillen P. M. E., Van der Noordaa J. 1990; Rapid and simple method for purification of nucleic acids. Journal of Clinical Microbiology 28:495–503
    [Google Scholar]
  5. Brettle R. P., Bisset K., Burns S., Davidson J., Davidson S. J., Gray J. M. N., Inglis J. M., Lees J. S., Mok J. 1987; Human immunodeficiency virus and drug misuse: the Edinburgh experience. British Medical Journal 295:421–424
    [Google Scholar]
  6. Buonocore L., Turi T. G., Crise B., Rose J. K. 1994; Stimulation of heterologous protein degradation by the Vpu protein of HIV-1 requires the transmembrane and cytoplasmic domains of CD4. Virology 204:482–486
    [Google Scholar]
  7. Chen M. Y., Maldarelli F., Karczewski M. K., Willey R. L., Strebel K. 1993; Human immunodeficiency virus type 1 Vpu protein induces degradation of CD4 in vitro: the cytoplasmic domain of CD4 contributes to Vpu sensitivity. Journal of Virology 67:3877–3884
    [Google Scholar]
  8. Ciesielsky C. A., Marianos D., Ou C. Y., Dumbaugh R., Berkelman R., Gooch B., Myers G., Luo C. C., Schochetman G., Howell J., Lasch A., Bell K., Economou N., Scott B., Furman L., Curran J., Jaffe H. 1992; Transmission of human immunodeficiency virus in a dental practice. Annals of Internal Medicine 166:798–805
    [Google Scholar]
  9. Coffin J. M. 1992; Genetic diversity and evolution of retroviruses. Current Topics in Microbiology and Immunology 176:143–164
    [Google Scholar]
  10. Cohen E. A., Terwilliger E. F., Sodroski J. G., Haseltine W.A. 1988; Identification of a protein encoded by the vpu gene of HIV-1. Nature 334:532–534
    [Google Scholar]
  11. Cohen E. A., Terwilliger E. F., Jalinoos Y., Proulx J., Sodroski J. G., Haseltine W. A. 1990; Identification of HIV-1 vpr product and function. Journal of Acquired Immune Deficiency Syndrome 3:11–18
    [Google Scholar]
  12. Connor R. I., Kuan Chen B., Choe S., Landau N. R. 1995; Vpr is required for efficient regulation of human immunodeficiency virus type 1 in mononuclear phagocytes. Virology 206:935–944
    [Google Scholar]
  13. Dedera D., Hu W., Van der Heyden N., Ratner L. 1989; Viral protein R of human immunodeficiency virus types 1 and 2 is dispensable for replication and cytopathogenicity in lymphoid cells. Journal of Virology 63:3205–3208
    [Google Scholar]
  14. Delassus S., Cheynier R., Wain-Hobson S. 1991; Evolution of human immunodeficiency virus type 1 nef and long terminal repeat sequences over 4 years in vivo and in vitro. Journal of Virology 65:1225–231
    [Google Scholar]
  15. De Wolf F., Goudsmit J., Paul D. A., Lange J. M. A., Hooykaas C., Schellekens P. T. A., Coutinho R. A., Van der Noordaa J. 1987; Risk of AIDS related complex and AIDS in homosexual men with persistent HIV antigenaemia. British Medical Journal 295:569–572
    [Google Scholar]
  16. De Wolf F., Hogervorst E., Goudsmit J., Fenyo E.-M., Rubsamen-Waigmann H., Holmes H., Galvao-Castro B., Karita E., Wasi C., Sempala S. D. K., Baan E., Zorgdrager F., Lukashov V. V., Osmanov S., Kuiken C. L., Cornelissen M. T. E. The WHO Network on HIV-1 Isolation & Characterization 1994; Syncytium-inducing (SI) and non-syncytiuminducing (NSI) capacity of human immunodeficiency virus type 1 (HIV-1) subtypes other than B: phenotypic and genotypic characteristics. AIDS Research and Human Retroviruses 10:1387–1400
    [Google Scholar]
  17. Diaz R. S., Sabino E. C., Mayer A., Mosley J. W., Busch M. P. 1995; Dual human immunodeficiency virus type 1 infection and recombination in a dually exposed transfusion recipient. Journal of Virology 69:3273–3281
    [Google Scholar]
  18. Haigwood N. L., Mason O. B., York-Higgins D., Korber B. T. M., Weiser B., Burger H. 1993; HIV-1 envelope sequence diversity in long-term infected asymptomatic patients. Vaccines233–242
    [Google Scholar]
  19. Hamming R. W. 1986 Coding & Information Theory 2nd edn Englewood Cliffs: Prentice Hall;
    [Google Scholar]
  20. Hattori N., Michaels F., Fargnoli K., Marcon L., Gallo R. C., Franchini G. 1990; The human immunodeficiency virus type 2 vpr gene is essential for productive infection of human macrophages. Proceedings of the National Academy of Sciences, USA 87:8080–8084
    [Google Scholar]
  21. Higgins D. G. 1992; Sequence ordinations: a multivariate analysis approach to analysing large sequence data sets. CABIOS 8:15–22
    [Google Scholar]
  22. Holmes E. C., Nee S., Rambaut A. R., Garnett G. P., Harvey P. H. 1995; Revealing the history of infectious disease epidemics through phylogenetic trees. Philosophical Transactions of the Royal Society of London 349:33–40
    [Google Scholar]
  23. Howell R. M., Fitzgibbon J. E., Noe M., Ren Z., Gocke D. J., Schwartzer T. A., Dubin D. T. 1991; In vivo sequence variation of the human immunodeficiency virus type 1 env gene: evidence for recombination among variants found in a single individual. AIDS Research and Human Retroviruses 7:869–876
    [Google Scholar]
  24. Kimura M. 1980; A simple method for estimating evolutionary rates of base substitution through comparative studies of nucleotide sequences. Journal of Molecular Evolution 16:111–120
    [Google Scholar]
  25. Klimkait T., Strebel K., Hoggan M. D., Martin M. A., Orenstein J. M. 1990; The human immunodeficiency virus type 1-specific protein vpu is required for efficient virus maturation and release. Journal of Virology 64:621–629
    [Google Scholar]
  26. Kuiken C. L., Goudsmit J. 1994; Silent mutation pattern in V3 sequences distinguishes virus according to risk group in Europe. AIDS Research and Human Retroviruses 10:319–320
    [Google Scholar]
  27. Kuiken C. L., Zwart G., Baan E., Coutinho R. A., Van den Hoek J. A. R., Goudsmit J. 1993; Increasing antigenic and genetic diversity of the HIV-1 V3 domain in the course of the AIDS epidemic. Proceedings of the National Academy of Sciences, USA 90:9061–9065
    [Google Scholar]
  28. Kuiken C. L., Lukashov V. V., Leunissen J. A. M., Goudsmit J. 1996; Restricted intra-patient evolution of genomic RNA encoding the third variable (V3) domain of the HIV-1 envelope. AIDS 10:31–37
    [Google Scholar]
  29. Kumar S., Tamura K., Nei M. 1994; MEGA: molecular evolutionary genetics analysis software for microcomputers. CABIOS 10:189–192
    [Google Scholar]
  30. Levy D. N., Fernandes L. S., Williams W. V., Weiner D. B. 1993; Induction of cell differentiation by human immunodeficiency type 1 vpr. Cell 72:541–550
    [Google Scholar]
  31. Levy D. N., Refaeli Y., MacGregor R. R., Weiner D. B. 1994; Serum vpr regulates productive infection and latency of human immunodeficiency virus type 1. Proceedings of the National Academy of Sciences, USA 91:10873–10877
    [Google Scholar]
  32. Monken C. E., Wu B., Srinivasan A. 1995; High resolution analysis of the HIV-1 quasispecies in the brain. AIDS 9:345–349
    [Google Scholar]
  33. Myers G., Wain-Hobson S., Henderson L. E., Korber B., Jeang K. T., Pavlakjs G. N. 1994 Human Retroviruses and AIDS 1994 Los Alamos, N. Mex.: Theoretical Biology and Biophysics Group;
    [Google Scholar]
  34. Nei M., Gojobori T. 1986; Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Molecular Biology and Evolution 3:418–426
    [Google Scholar]
  35. Ogawa K., Shibata R., Kiyomasu T., Higuchi I., Kishida Y., Ishimoto A., Adachi A. 1989; Mutational analysis of the human immunodeficiency virus vpr open reading frame. Journal of Virology 63:4110–4114
    [Google Scholar]
  36. Pedroza Martins L., Chenciner N., Asjo B., Meyerhans A., Wain-Hobson S. 1991; Independent fluctuation of human immunodeficiency virus type 1 rev and gp41 quasispecies in vivo. Journal of Virology 65:4502–4507
    [Google Scholar]
  37. Peutherer J. F., Edmond E., Simmonds P., Dickson J. D., Bath G. E. 1985; HTLV-III antibody in Edinburgh drug addicts. Lancet ii:1129–1130
    [Google Scholar]
  38. Raja N. U., Vincent M. J., Jabbar M. A. 1994; Vpu-mediated proteolysis of gp160/CD4 chimeric envelope glycoproteins in the endoplasmic reticulum: requirement of both the anchor and cytoplasmic domain of CD4. Virology 204:357–366
    [Google Scholar]
  39. Robertson D. L., Hahn B. H., Sharp P. M. 1995; Recombination in AIDS viruses. Journal of Molecular Evolution 40:249–259
    [Google Scholar]
  40. Rojas J. M., Dopazo J., Najera I., Sanchez-Palomino S., Olivares I., Martin M. J., Bernal A., Garcia Saiz A., Najera R., Lopez-Galindez C. 1994; Molecular epidemiology of HIV-1 in Madrid. Virus Research 31:331–342
    [Google Scholar]
  41. Saitou N., Nei M. 1987; The neighbor-joining method: a new method for reconstructing phylogenetic trees. Molecular Biology and Evolution 4:406–425
    [Google Scholar]
  42. Strebel K., Klimkait T., Maldarelli F., Martin M. A. 1989; Molecular and biochemical analyses of human immunodeficiency virus type 1 vpu protein. Journal of Virology 63:3784–3791
    [Google Scholar]
  43. Terwilliger E. F., Cohen E. A., Lu Y., Sodroski J. G., Haseltine W. A. 1989; Functional role of human immunodeficiency virus type 1 vpu. Proceedings of the National Academy of Sciences, USA 86:5163–5167
    [Google Scholar]
  44. Van den Hoek J. A. R., Coutinho R. A., Van Haastrecht H. J. A., Van Zadelhoff A. W., Goudsmit J. 1988; Prevalence and risk factors of HIV infections among drug users and drug-using prostitutes in Amsterdam. AIDS 2:55–60
    [Google Scholar]
  45. Vartanian J. P., Meyerhans A., Asjo B., Wain-Hobson S. 1991; Selection, recombination and G → A hypermutation of human immunodeficiency virus type 1 genomes. Journal of Virology 65:1779–1788
    [Google Scholar]
  46. Westervelt P., Henkel T., Trowbridge D. B., Orenstein J. M., Heuser J., Gendelman H. E., Ratner L. 1992; Dual regulation of silent and productive infection in monocytes by distinct human immunodeficiency virus type 1 determinants. Journal of Virology 66:3925–3931
    [Google Scholar]
  47. Willey R. L., Buckler-White A., Strebel K. 1994; Sequences present in the cytoplasmic domain of CD4 are necessary and sufficient to confer sensitivity to the human immunodeficiency virus type 1 Vpu protein. Journal of Virology 68:1207–1212
    [Google Scholar]
  48. Yuan X., Matsuda Z., Matsuda M., Essex M., Lee T.-H. 1990; Human immunodeficiency virus vpr gene encodes a virion-associated protein. AIDS Research and Human Retroviruses 6:1265–1271
    [Google Scholar]
  49. Zhu T., Mo H., Wang N., Nam D. S., Cao Y., Koup R. A., Ho D. D. 1993; Genotypic and phenotypic characterization of HIV-1 in patients with primary infection. Science 261:1179–1181
    [Google Scholar]
  50. Zhu T., Wang N., Carr A., Wolinsky S., Ho D. D. 1995; Evidence for coinfection by multiple strains of human immunodeficiency virus type 1 subtype B in an acute seroconvertor. Journal of Virology 69:1324–1327
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-77-4-783
Loading
/content/journal/jgv/10.1099/0022-1317-77-4-783
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error